Pot stocks analysts are confident that the CBD industry is about to make much more waves that can ever be imagined. This is because the $867 billion Farm Bill, signed into law by US President Donald Trump on December 20th, officially excluded all cannabis products with 0.3% or less THC from the Controlled Substances Act. (THC is the psychoactive element in marijuana that gets users “high.”)
CBD has medicinal uses and is already legal in many states, as is its psychoactive component. As a result, farmers anywhere in the United States can freely grow “hemp” for both industrial and medical purposes.
Canaccord, a wealth management firm and investment bank with offices around the globe believes the effects of CBD legalization will be huge. They rated the following stocks as most promising in a note today:
Canopy Growth Corporation (WEED-TSE)
Curaleaf Holdings, Inc. (CURA-CSE)
MJardin Group, Inc. (MJAR-CSE)
KushCo. Holdings, Inc. (KSHB-OTC)
Liberty Health Sciences Inc. (LHS-CSE)
1933 Industries, Inc. (TGIF-CSE)
Charlotte’s Web Holdings, Inc. (CWEB-CSE)
DionyMed Brands, Inc. (DYME-CSE)